D. Piper

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

C. Eng, M. Shinawi, U. Ramaswami, 2006, Genetics in Medicine.

One week triple therapy for Helicobacter pylori: a multicentre comparative study

C. O'Morain, B. Cooper, Boris OGUIBENINE, 1997, Gut.

Erratum: A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome) (Genetics in Medicine (August 2006) 8, 8, (465-473))

C. Eng, M. Shinawi, U. Ramaswami, 2006 .

Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors

Hong Wang, J. Wolchok, D. Davar, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma.

M. Birrer, M. Kagey, U. Matulonis, 2023, Gynecologic oncology.